The largest database of trusted experimental protocols

Mda mb 468

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, United Kingdom, China, Spain

The MDA-MB-468 is a cell line derived from a human breast adenocarcinoma. It is used in research applications to study cancer biology and drug development.

Automatically generated - may contain errors

186 protocols using mda mb 468

1

Breast Cancer Cell Line Culturing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer cell lines MDA-MB-231, MCF-7, BT-549, BT-20, MDA-MB-468 and HCC-1806 were obtained from American Type Culture Collection (ATTC, LGC Standards, London, UK). MDA-MB-231 and MCF-7 cell lines were cultured in DMEM/F-12 medium, BT-549, BT-20 and HCC-1806 cells in RPMI 1640 medium and MDA-MB-468 in DMEM high glucose medium (all from Gibco, Thermo Fisher Scientific, Madrid, Spain). All media were supplemented with 10% fetal bovine serum (FBS; Gibco, Thermo Fisher Scientific, Madrid, Spain), 1% antibiotic-antimycotic mixture, 2 mM L-glutamine, 1× non-essential amino acids and 1 mM of sodium pyruvate (all from Gibco, Thermo Fisher Scientific, Madrid, Spain). MDA-MB-231-, HCC1806- and MDA-MB-468-ALDH1A1:tdTomato CSC models, in which CSC can be identified by the expression of tdTomato fluorochrome [13 (link)], were cultured in complete medium supplemented with the selection antibiotic blasticidin at 1 μg/mL (Gibco, Thermo Fisher Scientific, Madrid, Spain). Of note, the stemness nature of tdTomato-expressing cells from all three-CSC models has already been fully confirmed in vitro by increased expression of stemness markers, mammosphere formation and in vivo tumorigenic capacity [13 (link)]. All cell lines were incubated in a humidified incubator at 37 °C containing 5% CO2.
+ Open protocol
+ Expand
2

Breast Cancer Cell Line Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human normal breast cell line MCF‐10A and BC cell lines MCF‐7 and MDA‐MB‐468 were acquired from American Type Culture Collection (Manassas, VA, USA). MCF‐10A cells were cultured in MEBM BulletKit (Lonza, Basel, Switzerland). MCF‐7 and MDA‐MB‐468 cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Sigma, Louis, Missouri, MO, USA) supplemented with fetal bovine serum (FBS, 10%, Sigma), streptomycin (100 μg/mL, Sigma), and penicillin (100 U/mL, Sigma). These cells were kept in a moist atmosphere with 5% CO2 at 37°C.
Small interference (si) RNA targeting circ_0000518 (si‐circ_0000518) and corresponding control (si‐NC), as well as miR‐326 mimic and inhibitor (miR‐326 and anti‐miR‐326) and their matching negative controls (miR‐NC and anti‐miR‐NC), were obtained from GenePharma (Shanghai, China). The overexpression vectors of FGFR1 (pcDNA‐FGFR1) and circ_0000518 (circ_0000518) were established via cloning the full‐length sequence of FGFR1 or circ_0000518 into the pcDNA3.1 vector (pcDNA‐NC) (Invitrogen, Carlsbad, CA, USA) or pcD‐ciR (Geneseed Biotech Co., Ltd., Guangzhou, China) (Vector). BC cells (MCF‐7 and MDA‐MB‐468) were transfected with oligonucleotides or vectors using Lipofectamine 3000 reagent (Life Technologies, Grand Island, NY, USA).
+ Open protocol
+ Expand
3

Cultivation of TNBC and non-TNBC Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines (TNBC, MDA-MB-468; non-TNBC, MCF-7) were provided by the Shanghai Type Culture Collection of the Chinese Academy of Sciences. MDA-MB-468 cells were cultivated with modified L-15 medium (Gibco, USA) containing 10% fetal bovine serum (FBS) (Gibco, USA) and 1% penicillin–streptomycin at 37 °C under a humidified atmosphere with 0% CO2. MCF-7 cells were cultivated with DMEM medium (10% FBS + 1% penicillin–streptomycin; 37 °C, 5% CO2).
+ Open protocol
+ Expand
4

Breast Cancer Tissue Collection and Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 10 pairs of breast cancer and matched adjacent noncancerous tissue samples were collected between 2014 and 2015 at Nanjing Drum Tower Hospital (Nanjing, China). All protocols concerning the use of patient samples in this study were approved by the Medical Ethics Committee from Nanjing University and Nanjing Drum Tower Hospital, and all patients signed informed consent for the collection and use of their tissues for this study. The methods were carried out in accordance with the approved guidelines by Nanjing University and Nanjing Drum Tower Hospital. The clinical data of these tissues are listed in Supplementary Table 1. Two human breast cancer cell lines, MCF-7 and MDA-MB-468, and an embryonic kidney cell line, 293 T, were purchased from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China). MCF-7 and 293 T cells were maintained in DMEM medium (Gibco, Carlsbad, CA, USA). MDA-MB-468 cells were maintained in 1640 medium (Gibco, Carlsbad, CA, USA). Medium was supplemented with 10% fetal bovine serum (FBS, Gibco, Carlsbad, CA, USA) and 1% penicillin/streptomycin (Gibco, Carlsbad, CA, USA). All cells were cultured in a humidified incubator at 37 °C with 5% CO2.
+ Open protocol
+ Expand
5

Culturing Human Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast adenocarcinoma (MCF-7, BT-474, MDA-MB-468 and MDA-MB-231) cell lines were obtained from the American Type Tissue Culture Collection (ATCC, USA). MCF-7-Tet-Off-HER2 cell line was kindly donated by Professor Joaquin Arribas and maintained as previously described (26 (link)). All cell lines were tested and authenticated by short tandem repeat (STR) DNA profiling analysis. The cells were cultured in DMEM (MCF-7, MDA-MB-231), RPMI1640 (BT-474, MDA-MB-468) or DMEM/Ham/F12 (MCF-7-Tet-Off-HER2) with high glucose (Gibco, Life Technologies, UK) and supplemented with 10% fetal bovine serum (FBS), (Gibco, Life Technologies, UK). Additionally, DMEM/Ham/F12 contained 1 μg/mL of doxycycline (Sigma, UK), 0.2 mg/mL of neomycin (Sigma, UK), and 0.1 mg/mL of hygromycin (Life Technologies, UK). All cell lines were maintained at 37°C in a humidified atmosphere supplied with 5% CO2.
+ Open protocol
+ Expand
6

Breast Cancer Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The breast cancer cell lines MDA-MB-231, MDA-MB-468, T47D, MCF-7 and the human mammary epithelial cell line MCF-12A, and nontumorigenic (fibrocystic disease) mammary gland epithelial cell line MCF-10A were purchased from the ATCC (Rockville, MD). These cells were authenticated by Laragen, Inc. (Culver City, CA), by short tandem repeat (STR) profiling and monitoring cell morphology and biological behavior, and tested to exclude mycoplasma contamination before experiments. MDA-MB-231, MDA-MB-468, T47D, MCF-7 cells were cultured in DMEM high glucose (Cat: 11965092, Gibco™) supplemented with 10% FBS (Cat: 16000044, Gibco™) and 1% penicillin/streptomycin (Cat:15140122, Gibco™). MCF-12A cells were cultured in DMEM/F12 medium (Lonza) supplemented with 100 ng/mL cholera toxin. MCF-10A were cultured in MEBM medium (Lonza) supplemented with 100 ng/mL cholera toxin. T47D cells were maintained in RPMI1640 medium (Lonza), 10% FBS, and 1% penicillin/streptomycin.
+ Open protocol
+ Expand
7

Establishment and Culture of Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HER2-positive cancer cell lines SKBR3 (human breast cancer cell), BT474 (human breast cancer cell), SKOV3 (human ovary cancer cell), MCF7 (human breast cancer cell), the HER2-negative cancer cell line MDAMB435, MDAMB468, the Chinese hamster ovary (CHO) were purchased from the Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China. SKBR3, SKOV3 and MDAMB435 were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Gibco, Life Technologies, China) with 10 % HI fetal bovine serum (Gibco, Life Technologies, USA) and 1 % Penicillin/Streptomycin (HyClone); BT474 and CHO were cultured in RPMI-1640 medium (Gibco, Life Technologies, China) with 10 % HI fetal bovine serum (Gibco, Life Technologies, USA) and 1 % Penicillin/Streptomycin (HyClone), MDAMB468 were cultured in L15 (Gibco, Life Technologies, China) at 37 °C in a 5 % CO2 humidified incubator.
Non-obese diabetic-severe combined immunodeficiency disease (NOD/SCID) mice were purchased and then housed in the animal experiment center of Sun Yat-sen University under sterile and standardized environmental conditions (20–26 °C room temperature, 40–70 % relative humidity, and 12 h light–dark rhythm).
+ Open protocol
+ Expand
8

Cell Line Characterization and Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 (HTB-26), MDA-MB-468 (HTB-132), MCF10A (CRL-10317), and MCF-7 (HTB-22) were purchased from ATCC in 2010 (MCF-7), 2012 (MDA-MB-468), and 2014 (MDA-MB-231 and MCF10A). Primary human fibroblast cells were kindly provided by Kathrin Scheckenbach, Düsseldorf, Germany in 2014. TMD231 cells were obtained from Dr. Harikrishna Nakshatri in 2009 and are a derivative of the MDA-MB-231 cell line (19 (link)). TMD231 cells were transduced with E2-Crimson lentiviral vector, p2CL7CR2wo, (TMD231-CR) for in vivo imaging as described (20 (link)). Upon receipt, cell stocks were cryopreserved at low passage. Authentication of molecular profiles was verified by short tandem repeat (STR) analysis (IDEXX BioResearch), and cells tested negative for mycoplasma. TMD231 cells were cultured in MEM-α (Gibco) supplemented with 10% FBS (Atlanta Biologicals) and 1% HEPES (Invitrogen). MDA-MB-231, MDA-MB-468, and primary human fibroblast cells were cultured in DMEM (Gibco) supplemented with 10% FBS (Atlanta Biologicals). MCF10A cells were cultured in Medium 171 (Gibco) supplemented with 1% MEGS (Invitrogen) and 0.1% cholera toxin (Sigma). All cells were cultured at 37°C with 5% CO2.
+ Open protocol
+ Expand
9

Culturing and Maintaining Human Breast Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male C57BL/6 (8–9 weeks old) mice were purchased from Vital River (Beijing, China). The human breast cell lines (BCap37, Hs 578T, MDA-MB-231, MDA-MB-468, BT-474, SK-BR-3, MCF-7, Hs 578Bst and HBL-100) were purchased from the cell bank of the Chinese Scientific Academy. BCap37, BT-474 and MCF-7 cells were cultured in Roswell Park Memorial Institute 1640 medium (Gibco, 31800105, Carlsbad, CA, USA) with 10% fetal bovine serum (FBS; Biological Industries, 04-0101-1, Cromwell, CT, USA). MDA-MB-231 and MDA-MB-468 cells were cultured in Leibovitz's L-15 medium (Gibco, 11415114) with 10% FBS. Hs 578T cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, 12430047) supplemented with 0.01 mg/ml bovine insulin (Solarbio, I8040, Beijing, China) and 10% FBS. SK-BR-3 cells were cultured in McCoy's 5A medium (modified, Gibco, 16600082) with 10% FBS. Hs 578Bst cells were cultured in DMEM with 50 ng/ml epidermal growth factor (Gibco, PHG0311) and 15% FBS. HBL-100 cells were cultured in DMEM with 10% FBS. The cell culture medium was changed every 2–3 days, and the cells were passaged with 0.25% trypsin-EDTA (Gibco, 25200056) and grown to 90% confluence. The cultures were kept at 37 °C with 5% CO2 in a water-jacketed incubator (Thermo Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
10

Comparative Cytotoxicity Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DAPT and gliotoxin, were obtained from Merck Millipore (Darmstadt, Germany). The compounds were reconstituted in dimethyl sulfoxide (DMSO). Human cell lines derived from melanoma (518A2), HCC (HEP3B, SNU398, Huh7), pancreas-CA (PANC1), and breast-CA (HCC38, MDA-MB-468) were cultured in RPMI 1640 supplemented with 10% heat inactivated fetal calf serum (FCS), 2 mM Glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (all reagents were obtained from Gibco, Life Technologies Inc., Paisley, United Kingdom). HEP3B (HB-8064), SNU398 (CRL-2233), PANC1 (CRL-1469), HCC38 (CRL-2314), and MDA-MB-468 (HTB-132) cell lines were obtained from the American Type Culture Collection (ATCC, Rockville, MA, United States). The cell line Huh7 (JCRBO 403) was obtained from the National Institute of Biomedical Innovation (Osaka, Japan). The melanoma cell line 518A2, characterized by the BRAF V600E mutation and a CDKN2A exon 2 deletion, was obtained from Leiden University. The generation of the HCC cell line HCC-3 was described previously (Winter et al., 2008 (link)). Cells were incubated with the indicated concentrations of inhibitors or with equal amounts of solvent.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!